You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Skin conditions
  5. Psoriasis

Infliximab for the treatment of adults with psoriasis

  • Technology appraisal guidance
  • Reference number: TA134
  • Published:  23 January 2008
  • Guidance
  • Tools and resources
  • Information for the public
  • History
Download guidance (PDF)
  • Overview
  • 1 Recommendations
  • 2 The technology
  • 3 The manufacturer's submission
  • 4 Consideration of the evidence
  • 5 Implementation
  • 6 Appraisal committee members and NICE project team
  • 7 Sources of evidence considered by the committee
  • Update information

Update information

March 2014: Implementation section updated to clarify that infliximab is recommended as an option for treating plaque psoriasis.

ISBN: 978-1-4731-7076-6


Previous page 7 Sources of evidence considered by the committee
Back to top